 effect recombin human erythropoietin lymphocyt subset hemodialysi patient lymphocyt subpopul immunofluoresc monoclon antibodi laser flow cytometri blood hemodialysi patient month treatment recombin human erythropoietin rhepo correct anemia increas natur killer cell decreas lymphocyt patient group baselin helper/suppressor ratio equal latter increas cell decreas cell patient pre-epo ratio group differ cell subset decreas ferritin level studi period signific addit mean increas hemoglobin level first month rhepo therapi group group g/dl chang paramet control patient rhepo result rhepo chang lymphocyt subpopul hemodialysi patient mechan ratio predict factor erythropoiet respons